SCHEMBL27466657

SCHEMBL27466657

Nc1cccc(C(=O)Nc2cccc(C(F)(F)F)c2)c1Cc1ccncc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS1 P23219 1/20 0.64
▸ KDR P35968 7/20 0.63
▸ FLT1 P17948 4/20 0.63
▸ ABL1 P00519 1/20 0.63
▸ EGFR P00533 1/20 0.63
▸ CSF1R P07333 1/20 0.63
▸ PDGFRB P09619 1/20 0.63
▸ KIT P10721 1/20 0.63
▸ FLT4 P35916 1/20 0.63
▸ RXFP1 Q9HBX9 6/20 0.58
▸ GAA P10253 1/20 0.55
▸ AHR P35869 1/20 0.55
▸ HSD17B10 Q99714 1/20 0.55
▸ P2RX1 P51575 2/20 0.53
▸ IDE P14735 1/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ MAPK10 P53779 1/20 0.52
▸ RXFP2 Q8WXD0 1/20 0.51
▸ MEN1 O00255 1/20 0.50
▸ TSHR P16473 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27548630 0.91 PTGS1 (0.63) PTGS1KDRFLT1ABL1EGFR
SCHEMBL27483851 0.89 PTGS1 (0.60) PTGS1KDRFLT1ABL1EGFR
SCHEMBL27467095 0.89 P2RX1 (0.54) PTGS1KDRFLT1ABL1EGFR
SCHEMBL27485593 0.88 KDR (0.56) PTGS1KDRFLT1ABL1EGFR
SCHEMBL27485592 0.87 KDR (0.57) PTGS1KDRFLT1ABL1EGFR
SCHEMBL4981385 0.86 KDR (0.68) KDRFLT1ABL1EGFRCSF1R
SCHEMBL17836886 0.85 PTGS1 (0.61) PTGS1RXFP1GAAAHRHSD17B10
SCHEMBL27468045 0.84 KDR (0.44) PTGS1KDRFLT1ABL1EGFR
SCHEMBL27486254 0.84 SMN1; SMN2 (0.53) KDR
SCHEMBL27485938 0.84 PRKCI (0.53) PTGS1KDRFLT1ABL1EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1152014-C N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors ��˹��ŵ�� 2004-06-02 — — CN claimed
CN-1331680-A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors NOVARTIS AG (CH) 2002-01-16 — — CN claimed
CN-1152014-C N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors ��˹��ŵ�� 2004-06-02 — — CN disclosed
CN-1331680-A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors NOVARTIS AG (CH) 2002-01-16 — — CN disclosed
Send feedback